BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice
Authors:
- 1 May 2014
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 154 (1) , 131-147
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Prevention of allergic airway hyperresponsiveness and remodeling in mice by Astragaliradix Antiasthmatic decoctionBMC Complementary and Alternative Medicine, 2013
- The Immunomodulatory Effect of You-Gui-Wan onDermatogoides-pteronyssinus-Induced AsthmaEvidence-Based Complementary and Alternative Medicine, 2012
- Depletion of alveolar macrophages prolongs survival in response to acute pneumovirus infectionVirology, 2012
- Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in miceJournal of Clinical Investigation, 2009
- Efficacy and mechanisms of action of traditional Chinese medicines for treating asthma and allergyJournal of Allergy and Clinical Immunology, 2009
- Clearance of influenza virus from the lung depends on migratory langerin+CD11b− but not plasmacytoid dendritic cellsJournal of Experimental Medicine, 2008
- Distinct roles for IL-13 and IL-4 via IL-13 receptor α1 and the type II IL-4 receptor in asthma pathogenesisProceedings of the National Academy of Sciences, 2008
- TH-17 cells in the circle of immunity and autoimmunityNature Immunology, 2007
- In vivo treatment with the herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium-induced colitisClinical and Experimental Immunology, 2007
- Mortality in Patients Hospitalized for Asthma Exacerbations in the United StatesAmerican Journal of Respiratory and Critical Care Medicine, 2006